HIV RNA suppression and immune restoration: Can we do better?

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Pinzone, Marilia Rita ^a   Di Rosa, Michelino ^a   Cacopardo, Bruno ^a   Nunnari, Giuseppe ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS DNA; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

CD4+ T LYMPHOCYTE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE RESTORATION; IMMUNOMODULATION; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIREMIA; VIRUS LATENCY; BIOSYNTHESIS; CD4 LYMPHOCYTE COUNT; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; VIROLOGY; VIRUS ACTIVATION;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; RNA, VIRAL; TREATMENT OUTCOME; VIREMIA; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84859733555     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/515962     Document Type: Review

References (149)

1. Palella F. J., Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection The New England Journal of Medicine 1998 338 13 853 860 (Pubitemid 28135961)
2. Hammer S. M., Squires K. E., Hughes M. D., Grimes J. M., Demeter L. M., Currier J. S., Eron Jr. J. J., Feinberg J. E., Balfour H. H. Jr., Deyton L. R., Chodakewitz J. A., Fischl M. A., Phair J. P., Spreen W., Pedneault L., Nguyen B.-Y., Cook J. C., A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less The New England Journal of Medicine 1997 337 11 725 733 (Pubitemid 27417971)
3. Gulick R. M., Mellors J. W., Havlir D., Eron J. J., Gonzalez C., McMahon D., Richman D. D., Valentine F. T., Jonas L., Meibohm A., Emini E. A., Chodakewitz J. A., Deutsch P., Holder D., Schleif W. A., Condra J. H., Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy The New England Journal of Medicine 1997 337 11 734 739 (Pubitemid 27417972)
4. Havlir D. V., Koelsch K. K., Strain M. C., Margot N., Lu B., Ignacio C. C., Miller M. D., Wong J. K., Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine Journal of Infectious Diseases 2005 191 7 1164 1168 (Pubitemid 40404376)
5. Palmer S., Wiegand A. P., Maldarelli F., Bazmi H., Mican J. M., Polis M., Dewar R. L., Planta A., Liu S., Metcalf J. A., Mellors J. W., Coffin J. M., New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma Journal of Clinical Microbiology 2003 41 10 4531 4536 (Pubitemid 37259753)
6. Palmer S., Maldarelli F., Wiegand A., Bernstein B., Hanna G. J., Brun S. C., Kempf D. J., Mellors J. W., Coffin J. M., King M. S., Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy Proceedings of the National Academy of Sciences of the United States of America 2008 105 10 3879 3884 (Pubitemid 351723493)
7. Dornadula G., Zhang H., VanUitert B., Stern J., Livornese L., Ingerman M. J., Witek J., Kedanis R. J., Natkin J., DeSimone J., Pomerantz R. J., Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy JAMA 1999 282 17 1627 1632 (Pubitemid 29513968)
8. Lewin S. R., Rouzioux C., HIV cure and eradication: how will we get from the laboratory to effective clinical trials? AIDS 2011 25 7 885 897
9. Kelley C. F., Kitchen C. M. R., Hunt P. W., Rodriguez B., Hecht F. M., Kitahata M., Crane H. M., Willig J., Mugavero M., Saag M., Martin J. N., Deeks S. G., Incomplete peripheral CD4 + cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment Clinical Infectious Diseases 2009 48 6 787 794
10. Kaufmann G. R., Perrin L., Pantaleo G., CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV cohort study Archives of Internal Medicine 2003 163 18 2187 2195 (Pubitemid 37248783)
11. Kaufmann G. R., Bloch M., Finlayson R., Zaunders J., Smith D., Cooper D. A., The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy AIDS 2002 16 3 359 367 (Pubitemid 34165367)
12. Moore R. D., Keruly J. C., CD4 + cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression Clinical Infectious Diseases 2007 44 3 441 446 (Pubitemid 46147630)
13. Althoff K. N., Justice A. C., Gange S. J., Deeks S. G., Saag M. S., Silverberg M. J., Gill M. J., Lau B., Napravnik S., Tedaldi E., Klein M. B., Gebo K. A., Virologic and immunologic response to HAART, by age and regimen class AIDS 2010 24 16 2469 2479
14. Viard J. P., Mocroft A., Chiesi A., Kirk O., Rge B., Panos G., Vetter N., Bruun J. N., Johnson M., Lundgren J. D., Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study Journal of Infectious Diseases 2001 183 8 1290 1294 (Pubitemid 32281572)
15. Tarwater P. M., Margolick J. B., Jin J., Phair J. P., Detels R., Rinaldo C., Giorgi J., Muoz A., Increase and plateau of CD4 T-cell counts in the 3 1/2 years after initiation of potent antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 2001 27 2 168 175 (Pubitemid 32595168)
16. Kaufmann G. R., Furrer H., Ledergerber B., Characteristics, determinants, and clinical relevance of CD4 T cell recovery to 500 cells/ L in HIV type 1-infected individuals receiving potent antiretroviral therapy Clinical Infectious Diseases 2005 41 3 361 372 (Pubitemid 41022115)
17. Egger S., Petoumenos K., Kamarulzaman A., Hoy J., Sungkanuparph S., Chuah J., Falster K., Zhou J., Law M. G., Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: the asia pacific HIV observational database (APHOD) Journal of Acquired Immune Deficiency Syndromes 2009 50 5 513 520
18. Florence E., Lundgren J., Dreezen C., Fisher M., Kirk O., Blaxhult A., Panos G., Katlama C., Vella S., Phillips A., van Lunzen J., Stellbrink H. J., Staszewski S., Goebel F. D., Salzberger B., Rockstroh J., Kosmidis J., Gargalianos P., Sambatakou H., Perdios J., Panos G., Karydis I., Banhegyi D., Mulcahy F., Yust I., Turner D., Pollack S., Ben-Ishai Z., Bentwich Z., Maayan S., Vella S., Chiesi A., Arici C., Prister R., Mazzotta F., Gabbuti A., Esposito R., Bedini A., Chirianni A., Montesarchio E., Vullo V., Santopadre P., Narciso P., Antinori A., Franci P., Zaccarelli M., Lazzarin A., Finazzi R., D'Arminio Monforte A., Viksna L., Chaplinkas S., Hemmer R., Reiss P., Bruun J., Maeland A., Ormaasen V., Knysz B., Gasiorowski J., Horban A., Prokopowicz D., Wiercinska-Drapalo A., Boron-Kaczmarska A., Pynka M., Beniowski M., Trocha H., Antunes F., Mansinho K., Proenca R., Duiculescu D., Mikras M., Gonzlez-Lahoz J., Diaz B., Garca-Benayas T., Martin-Carbonero L., Clotet B., Jou A., Conejero J., Tural C., Gatell J. M., Mir J. M., Blaxhult A., Karlsson A., Pehrson P., Ledergerber B., Weber R., Francioli P., Telenti A., Hirschel B., Soravia-Dunand V., Barton S., Johnson A. M., Mercey D., Phillips C., Loveday C., Johnson M. A., Mocroft A., Pinching A., Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study HIV Medicine 2003 4 3 255 262 (Pubitemid 36949882)
19. Castagna A., Galli L., Torti C., Monforte A. D., Mussini C., Antinori A., Cozzi-Lepri A., Ladisa N., De Luca A., Seminari E., Gianotti N., Lazzarin A., Predicting the magnitude of short-term CD4 + T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy Antiviral Therapy 2010 15 2 165 175
20. Smith C. J., Sabin C. A., Youle M. S., Kinloch-De Loes S., Lampe F. C., Madge S., Cropley I., Johnson M. A., Philips A. N., Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy Journal of Infectious Diseases 2004 190 10 1860 1868 (Pubitemid 39487833)
21. Hunt P. W., Deeks S. G., Rodriguez B., Valdez H., Shade S. B., Abrams D. I., Kitahata M. M., Krone M., Neilands T. B., Brand R. J., Lederman M. M., Martin J. N., Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy AIDS 2003 17 13 1907 1915 (Pubitemid 37070276)
22. Falster K., Petoumenos K., Chuah J., Mijch A., Mulhall B., Kelly M., Cooper D. A., Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression Journal of Acquired Immune Deficiency Syndromes 2009 50 3 307 313
23. Isgr A., Leti W., De Santis W., Marziali M., Esposito A., Fimiani C., Luzi G., Pinti M., Cossarizza A., Aiuti F., Mezzaroma I., Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4 + T cell counts despite viral suppression during HAART Clinical Infectious Diseases 2008 46 12 1902 1910
24. Kulkosky J., Bouhamdan M., Geist A., Nunnari G., Phinney D. G., Pomerantz R. J., Pathogenesis of HIV-1 infection within bone marrow cells Leukemia and Lymphoma 2000 37 5-6 497 515 (Pubitemid 30219058)
25. Ruiz-Mateos E., Rubio A., Vallejo A., De La Rosa R., Sanchez-Quijano A., Lissen E., Leal M., Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4 + T cells in HIV-infected adults after highly active antiretroviral therapy (HAART) Clinical and Experimental Immunology 2004 136 3 501 506 (Pubitemid 38703684)
26. Smith K. Y., Valdez H., Landay A., Spritzler J., Kessler H. A., Connick E., Kuritzkes D., Gross B., Francis I., McCune J. M., Lederman M. M., Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy Journal of Infectious Diseases 2000 181 1 141 147 (Pubitemid 30049042)
27. Teixeira L., Valdez H., McCune J. M., Koup R. A., Badley A. D., Hellerstein M. K., Napolitano L. A., Douek D. C., Mbisa G., Deeks S., Harris J. M., Barbour J. D., Gross B. H., Francis I. R., Halvorsen R., Asaad R., Lederman M. M., Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function AIDS 2001 15 14 1749 1756 (Pubitemid 32939234)
28. Ahuja S. K., Kulkarni H., Catano G., Agan B. K., Camargo J. F., He W., O'Connell R. J., Marconi V. C., Delmar J., Eron J., Clark R. A., Frost S., Martin J., Ahuja S. S., Deeks S. G., Little S., Richman D., Hecht F. M., Dolan M. J., CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals Nature Medicine 2008 14 4 413 420 (Pubitemid 351499392)
29. Du D. L., Volpe D. A., Grieshaber C. K., Murphy M. J., In vitro toxicity of 3'-azido-3'-deoxythymidine, carbovir and 2′, 3′ -dihydro- 2′, 3′ -dideoxythymidine to human and murine haematopoietic progenitor cells British Journal of Haematology 1992 80 4 437 445
30. Karrer U., Ledergerber B., Furrer H., Elzi L., Battegay M., Cavassini M., Gayet-Ageron A., Hirschel B., Schmid P., Russotti M., Weber R., Speck R. F., Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir AIDS 2005 19 17 1987 1994 (Pubitemid 41669023)
31. Viora M., Di Genova G., Rivabene R., Malorni W., Fattorossi A., Interference with cell cycle progression and induction of apoptosis by dideoxynucleoside analogs International Journal of Immunopharmacology 1997 19 6 311 321 (Pubitemid 28025427)
32. Piconi S., Trabattoni D., Gori A., Parisotto S., Magni C., Meraviglia P., Bandera A., Capetti A., Rizzardini G., Clerici M., Immune activation, apoptosis, and treg activity are associated with persistently reduced CD4 + T-cell counts during antiretroviral therapy AIDS 2010 24 13 1991 2000
33. Lederman M. M., Connick E., Landay A., Kuritzkes D. R., Spritzler J., Clair M. S., Kotzin B. L., Fox L., Chiozzi M. H., Leonard J. M., Rousseau F., Wade M., Roe J. D., Martinez A., Kessler H., Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of Zidovudine, Lamivudine, and Ritonavir: results of AIDS clinical trials group protocol 315 Journal of Infectious Diseases 1998 178 1 70 79 (Pubitemid 28328078)
34. Guihot A., Tubiana R., Breton G., Marcelin A. G., Samri A., Assoumou L., Goncalves E., Bricaire F., Costagliola D., Calvez V., Rouzioux C., Autran B., Katlama C., Carcelain G., Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy AIDS 2010 24 4 614 617
35. Ledergerber B., Lundgren J. D., Walker A. S., Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral drug classes The Lancet 2004 364 9428 51 62
36. Bucy R. P., Hockett R. D., Derdeyn C. A., Saag M. S., Squires K., Sillers M., Mitsuyasu R. T., Kilby J. M., Initial increase in blood CD4 + lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues The Journal of Clinical Investigation 1999 103 10 1391 1398 (Pubitemid 29535495)
37. Le Moing V., Thiébaut R., Chne G., Leport C., Cailleton V., Michelet C., Fleury H., Herson S., Raffi F., Predictors of long-term increase in CD4 + cell counts in human immunodeficiency virusinfected patients receiving a protease inhibitorcontaining antiretroviral regimen Journal of Infectious Diseases 2002 185 4 471 480 (Pubitemid 34142809)
38. Lok J. J., Bosch R. J., Benson C. A., Collier A. C., Robbins G. K., Shafer R. W., Hughes M. D., Long-term increase in CD4 + T-cell counts during combination antiretroviral therapy for HIV-1 infection AIDS 2010 24 12 1867 1876
39. Lederman M. M., McKinnis R., Kelleher D., Cutrell A., Mellors J., Neisler M., Cooney E., Haas D. W., Haubrich R., Stanford J., Horton J., Landay A., Spreen W., Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase AIDS 2000 14 17 2635 2642 (Pubitemid 32118716)
40. Tsukamoto H., Clise-Dwyer K., Huston G. E., Duso D. K., Buck A. L., Johnson L. L., Haynes L., Swain S. L., Age-associated increase in lifespan of nave CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects Proceedings of the National Academy of Sciences of the United States of America 2009 106 43 18333 18338
41. Chehimi J., Azzoni L., Farabaugh M., Creer S. A., Tomescu C., Hancock A., Mackiewicz A., D'Alessandro L., Ghanekar S., Foulkes A. S., Mounzer K., Kostman J., Montaner L. J., Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment Journal of Immunology 2007 179 4 2642 2650
42. Azzoni L., Papasavvas E., Chehimi J., Kostman J. R., Mounzer K., Ondercin J., Perussia B., Montaner L. J., Sustained impairment of IFN- secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity Journal of Immunology 2002 168 11 5764 5770 (Pubitemid 34556161)
43. Stone S. F., Price P., French M. A., Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy HIV Medicine 2005 6 4 278 283 (Pubitemid 41025293)
44. Baker J. V., Peng G., Rapkin J., Abrams D. I., Silverberg M. J., MacArthur R. D., Cavert W. P., Henry W. K., Neaton J. D., CD4 + count and risk of non-AIDS diseases following initial treatment for HIV infection AIDS 2008 22 7 841 848 (Pubitemid 351563833)
45. Baker J. V., Peng G., Rapkin J., Krason D., Reilly C., Cavert W. P., Abrams D. I., MacArthur R. D., Henry K., Neaton J. D., Poor initial CD4 + recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases Journal of Acquired Immune Deficiency Syndromes 2008 48 5 541 546
46. Reekie J., Kosa C., Engsig F., Monforte A. D., Wiercinska-Drapalo A., Domingo P., Antunes F., Clumeck N., Kirk O., Lundgren J. D., Mocroft A., Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies Cancer 2010 116 22 5306 5315
47. Gazzola L., Tincati C., Bellistr G. M., Monforte A. D., Marchetti G., The absence of CD4 + T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options Clinical Infectious Diseases 2009 48 3 328 337
48. Corbeau P., Reynes J., Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection Blood 2011 117 21 5582 5590
49. Pido-Lopez J., Imami N., Aspinall R., Both age and gender affect thymic output: more recent thymic migrants in females than males as they age Clinical and Experimental Immunology 2001 125 3 409 413 (Pubitemid 34155437)
50. Benveniste O., Flahault A., Rollot F., Elbim C., Estaquier J., Pédron B., Duval X., Dereuddre-Bosquet N., Clayette P., Sterkers G., Simon A., Ameisen J. C., Leport C., Mechanisms involved in the low-level regeneration of CD4 + cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads Journal of Infectious Diseases 2005 191 10 1670 1679 (Pubitemid 40656755)
51. Torti C., Cologni G., Uccelli M. C., Quiros-Roldan E., Imberti L., Airo P., Pirovano S., Patroni A., Tirelli V., Carosi G., Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART) Viral Immunology 2004 17 2 279 286 (Pubitemid 38880427)
52. Li T., Wu N., Dai Y., Qiu Z., Han Y., Xie J., Zhu T., Li Y., Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy Clinical Infectious Diseases 2011 53 9 944 951
53. Beq S., Delfraissy J. F., Theze J., Interleukin-7 (IL-7): immune function, involvement in the pathogenesis of HIV infection and therapeutic potential European Cytokine Network 2004 15 4 279 289 (Pubitemid 40127652)
54. Napolitano L. A., Grant R. M., Deeks S. G., Schmidt D., De Rosa S. C., Herzenberg L. A., Herndier B. G., Andersson J., Mccune J. M., Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis Nature Medicine 2001 7 1 73 79 (Pubitemid 32095644)
55. Marziali M., De Santis W., Carello R., Leti W., Esposito A., Isgr A., Fimiani C., Sirianni M. C., Mezzaroma I., Aiuti F., T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART AIDS 2006 20 16 2033 2041 (Pubitemid 44611056)
56. Molloy E. J., O'Neill A. J., Grantham J. J., Sheridan-Pereira M., Fitzpatrick J. M., Webb D. W., Watson R. W. G., Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone Blood 2003 102 7 2653 2659 (Pubitemid 37193609)
57. Olsen N. J., Kovacs W. J., Evidence that androgens modulate human thymic T cell output Journal of Investigative Medicine 2011 59 1 32 35
58. Camargo J. F., Quinones M. P., Mummidi S., Srinivas S., Gaitan A. A., Begum K., Jimenez F., VanCompernolle S., Unutmaz D., Ahuja S. S., Ahuja S. K., CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation Journal of Immunology 2009 182 1 171 182
59. MacArthur R. D., Novak R. M., Peng G., Chen L., Xiang Y., Hullsiek K. H., Kozal M. J., van den Berg-Wolf M., Henely C., Schmetter B., Dehlinger M., A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial The Lancet 2006 368 9553 2125 2135 (Pubitemid 44894557)
60. Torti C., Maggiolo F., Patroni A., Suter F., Ladisa N., Paraninfo G., Pierotti P., Orani A. M., Minoli L., Arici C., Sighinolfi L., Tinelli C., Carosi G., Cristini G., Casari S., Castelnuovo F., Forleo M. A., Lapadula G., Moretti F., Nasta P., Quiros-Roldan E., Tirelli V., Uccelli M. C., Ripamonti D., Suter F., Pastore G., Antinori A., Antonucci G., Lo Caputo S., Mazzotta F., Maserati R., Novati S., Ghinelli F., Mondello P., Carnevale G., Dionisio D., Vivarelli A., Rizzardini G., Migliorino P., Labate L., Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort Journal of Antimicrobial Chemotherapy 2005 56 1 190 195 (Pubitemid 41418356)
61. Riddler S. A., Haubrich R., DiRienzo A. G., Peeples L., Powderly W. G., Klingman K. L., Garren K. W., George T., Rooney J. F., Brizz B., Lalloo U. G., Murphy R. L., Swindells S., Havlir D., Mellors J. W., Class-sparing regimens for initial treatment of HIV-1 infection The New England Journal of Medicine 2008 358 20 2095 2106 (Pubitemid 351679596)
62. Bartlett J. A., Fath M. J., DeMasi R., Hermes A., Quinn J., Mondou E., Rousseau F., An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults AIDS 2006 20 16 2051 2064 (Pubitemid 44611058)
63. Lu W., Andrieu J. M., HIV protease inhibitors restore impaired T-cell proliferative response in vivo and in vitro: a viral-suppression-independent mechanism Blood 2000 96 1 250 258 (Pubitemid 30456478)
64. Sloand E. M., Kumar P. N., Kim S., Chaudhuri A., Weichold F. F., Young N. S., Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4 + T cells and decreases their susceptibility to apoptosis in vitro and in vivo Blood 1999 94 3 1021 1027 (Pubitemid 29361834)
65. Gandhi R. T., Spritzler J., Chan E., Asmuth D. M., Rodriguez B., Merigan T. C., Hirsch M. S., Shafer R. W., Robbins G. K., Pollard R. B., Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384 Journal of Acquired Immune Deficiency Syndromes 2006 42 4 426 434 (Pubitemid 44050889)
66. Marchetti G., Bellistr G. M., Borghi E., Tincati C., Ferramosca S., La Francesca M., Morace G., Gori A., Monforte A. D., Microbial translocation is associated with sustained failure in CD4 + T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy AIDS 2008 22 15 2035 2044
67. Ostrowski S. R., Katzenstein T. L., Thim P. T., Pedersen B. K., Gerstoft J., Ullum H., Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy Journal of Infectious Diseases 2005 191 3 348 357 (Pubitemid 40139759)
68. Massanella M., Negredo E., Pérez-lvarez N., Puig J., Ruiz-Hernndez R., Bofill M., Clotet B., Blanco J., CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART AIDS 2010 24 7 959 968
69. Negredo E., Massanella M., Puig J., Pérez-lvarez N., Gallego-Escuredo J. M., Villarroya J., Villarroya F., Molt J., Santos J. R., Clotet B., Blanco J., Nadir CD4 T cell count as predictor and high CD4 T cell intrinsic apoptosis as final mechanism of poor CD4 T cell recovery in virologically suppressed HIV-infected patients: clinical implications Clinical Infectious Diseases 2010 50 9 1300 1308
70. Appay V., Sauce D., Immune activation and inflammation in HIV-1 infection: causes and consequences Journal of Pathology 2008 214 2 231 241 (Pubitemid 351160160)
71. Paiardini M., Frank I., Pandrea I., Apetrei C., Silvestri G., Mucosal immune dysfunction in AIDS pathogenesis AIDS Reviews 2008 10 1 36 46 (Pubitemid 351524050)
72. Brenchley J. M., Schacker T. W., Ruff L. E., Price D. A., Taylor J. H., Beilman G. J., Nguyen P. L., Khoruts A., Larson M., Haase A. T., Douek D. C., CD4 + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract Journal of Experimental Medicine 2004 200 6 749 759 (Pubitemid 39299461)
73. Brenchley J. M., Price D. A., Schacker T. W., Asher T. E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B. R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J. N., Hecht F. M., Picker L. J., Lederman M. M., Deeks S. G., Douek D. C., Microbial translocation is a cause of systemic immune activation in chronic HIV infection Nature Medicine 2006 12 12 1365 1371 (Pubitemid 44924494)
74. Jiang W., Lederman M. M., Hunt P., Sieg C. F., Haley K., Rodriguez B., Landay A., Martin J., Sinclair E., Asher A. I., Deeks S. G., Douek D. C., Brenchley J. M., Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection Journal of Infectious Diseases 2009 199 8 1177 1185
75. Gonzalez V. D., Falconer K., Blom K. G., Reichard O., Mrn B., Laursen A. L., Weis N., Alaeus A., Sandberg J. K., High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment Journal of Virology 2009 83 21 11407 11411
76. Greub G., Ledergerber B., Battegay M., Grob P., Perrin L., Furrer H., Burgisser P., Erb P., Boggian K., Piffaretti J. C., Hirschel B., Janin P., Francioli P., Flepp M., Telenti A., Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the swiss HIV cohort study The Lancet 2000 356 9244 1800 1805
77. Potter M., Odueyungbo A., Yang H., Saeed S., Klein M. B., Impact of hepatitis C viral replication on CD4 + T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy AIDS 2010 24 12 1857 1865
78. Villacres M. C., Lacey S. F., La Rosa C., Krishnan R., Auge C., Longmate J., Zaia J. A., Leedom J. M., Diamond D. J., Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus Journal of Infectious Diseases 2001 184 3 256 267 (Pubitemid 32662171)
79. Fletcher J. M., Vukmanovic-Stejic M., Dunne P. J., Birch K. E., Cook J. E., Jackson S. E., Salmon M., Rustin M. H., Akbar A. N., Cytomegalovirus- specific CD4 + T cells in healthy carriers are continuously driven to replicative exhaustion Journal of Immunology 2005 175 12 8218 8225 (Pubitemid 41798386)
80. Shen L., Siliciano R. F., Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection Journal of Allergy and Clinical Immunology 2008 122 1 22 28 (Pubitemid 351899083)
81. Joos B., Fischer M., Kuster H., Pillai S. K., Wong J. K., Bni J., Hirschel B., Weber R., Trkola A., Gnthard H. F., Battegay M., Bernasconi E., Bni J., Bucher H. C., Brgisser P., Calmy A., Cattacin S., Cavassini M., Dubs R., Egger M., Elzi L., Fischer M., Flepp M., Fontana A., Francioli P., Furrer H., Fux C., Gorgievski M., Gnthard H., Hirsch H., Hirschel B., Hsli I., Kahlert C., Kaiser L., Karrer U., Kind C., Klimkait T., Ledergerber B., Martinetti G., Martinez B., Mller N., Nadal D., Paccaud F., Pantaleo G., Rauch A., Regenass S., Rickenbach M., Rudin C., Schmid P., Schultze D., Schpbach J., Speck R., Taffé P., Telenti A., Trkola A., Vernazza P., Weber R., Yerly S., HIV rebounds from latently infected cells, rather than from continuing low-level replication Proceedings of the National Academy of Sciences of the United States of America 2008 105 43 16725 16730
82. Dinoso J. B., Kim S. Y., Wiegand A. M., Palmer S. E., Gange S. J., Cranmer L., O'Shea A., Callender M., Spivak A., Brennan T., Kearney M. F., Proschan M. A., Mican J. M., Rehm C. A., Coffin J. M., Mellors J. W., Siliciano R. F., Maldarelli F., Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy Proceedings of the National Academy of Sciences of the United States of America 2009 106 23 9403 9408
83. McMahon D., Jones J., Wiegand A., Gange S. J., Kearney M., Palmer S., McNulty S., Metcalf J. A., Acosta E., Rehm C., Coffin J. M., Mellors J. W., Maldarelli F., Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy Clinical Infectious Diseases 2010 50 6 912 919
84. Hatano H., Hayes T. L., Dahl V., Sinclair E., Lee T.-H., Hoh R., Lampiris H., Hunt P. W., Palmer S., McCune J. M., Martin J. N., Busch M. P., Shacklett B. L., Deeks S. G., A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4 + T cell response Journal of Infectious Diseases 2011 203 7 960 968
85. Gandhi R. T., Zheng L., Bosch R. J., Chan E. S., Margolis D. M., Read S., Kallungal B., Palmer S., Medvik K., Lederman M. M., Alatrakchi N., Jacobson J. M., Wiegand A., Kearney M., Coffin J. M., Mellors J. W., Eron J. J., The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial PLoS Medicine 2010 7 8
86. Maldarelli F., Palmer S., King M. S., Wiegand A., Polis M. A., Mican J., Kovacs J. A., Davey R. T., Rock-Kress D., Dewar R., Liu S., Metcalf J. A., Rehm C., Brun S. C., Hanna G. J., Kempf D. J., Coffin J. M., Mellors J. W., ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia PLoS Pathogens 2007 3 4, article e46
87. Sharkey M. E., Teo I., Greenough T., Sharova N., Luzuriaga K., Sullivan J. L., Bucy R. P., Kostrikis L. G., Haase A., Veryard C., Davaro R. E., Cheeseman S. H., Daly J. S., Bova C., Ellison R. T., Mady B., Lai K. K., Moyle G., Nelson M., Gazzard B., Shaunak S., Stevenson M., Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy Nature Medicine 2000 6 1 76 81 (Pubitemid 30048530)
88. J Buzn M., Massanella M., Llibre J. M., Esteve A., Dahl V., Puertas M. C., Gatell J. M., Domingo P., Paredes R., Sharkey M., Palmer S., Stevenson M., Clotet B., Blanco J., Martinez-Picado J., HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects Nature Medicine 2010 16 4 460 465
89. Chomont N., El-Far M., Ancuta P., Trautmann L., Procopio F. A., Yassine-Diab B., Boucher G., Boulassel M. R., Ghattas G., Brenchley J. M., Schacker T. W., Hill B. J., Douek D. C., Routy J. P., Haddad E. K., Sékaly R. P., HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation Nature Medicine 2009 15 8 893 900
90. Churchill M. J., Gorry P. R., Cowley D., Lal L., Sonza S., Purcell D. F. J., Thompson K. A., Gabuzda D., McArthur J. C., Pardo C. A., Wesselingh S. L., Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues Journal of NeuroVirology 2006 12 2 146 152 (Pubitemid 44574605)
91. Gorry P., Purcell D., Howard J., McPhee D., Restricted HIV-1 infection of human astrocytes: potential role of nef in the regulation of virus replication Journal of NeuroVirology 1998 4 4 377 386 (Pubitemid 28395718)
92. Ellery P. J., Tippett E., Chiu Y. L., Paukovics G., Cameron P. U., Solomon A., Lewin S. R., Gorry P. R., Jaworowski A., Greene W. C., Sonza S., Crowe S. M., The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo Journal of Immunology 2007 178 10 6581 6589 (Pubitemid 46717442)
93. Dai J., Agosto L. M., Baytop C., Yu J. J., Pace M. J., Liszewski M. K., O'Doherty U., Human immunodeficiency virus integrates directly into nave resting CD4 + T cells but enters nave cells less efficiently than memory cells Journal of Virology 2009 83 9 4528 4537
94. Wightman F., Solomon A., Khoury G., Green J. A., Gray L., Gorry P. R., Ho Y. S., Saksena N. K., Hoy J., Crowe S. M., Cameron P. U., Lewin S. R., Both CD31 + and CD31 - naive CD4 + T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy Journal of Infectious Diseases 2010 202 11 1738 1748
95. Brooks D. G., Kitchen S. G., Kitchen C. M. R., Scripture-Adams D. D., Zack J. A., Generation of HIV latency during thymopoiesis Nature Medicine 2001 7 4 459 464 (Pubitemid 32298549)
96. Chun T. W., Nickle D. C., Justement J. S., Meyers J. H., Roby G., Hallahan C. W., Kottilil S., Moir S., Mican J. M., Mullins J. I., Ward D. J., Kovacs J. A., Mannon P. J., Fauci A. S., Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy Journal of Infectious Diseases 2008 197 5 714 720 (Pubitemid 351364472)
97. Petito C. K., Human immunodeficiency virus type 1 compartmentalization in the central nervous system Journal of NeuroVirology 2004 10 1 21 24 (Pubitemid 38325089)
98. Sheth P. M., Kovacs C., Kemal K. S., Jones R. B., Raboud J. M., Pilon R., La Porte C., Ostrowski M., Loutfy M., Burger H., Weiser B., Kaul R., Persistent HIV RNA shedding in semen despite effective antiretroviral therapy AIDS 2009 23 15 2050 2054
99. Nunnari G., Leto D., Sullivan J., Xu Y., Mehlman K. E., Kulkosky J., Pomerantz R. J., Seminal reservoirs during an HIV type 1 eradication trial AIDS Research and Human Retroviruses 2005 21 9 768 775 (Pubitemid 41434181)
100. Nunnari G., Sullivan J., Xu Y., Nyirjesy P., Kulkosky J., Cavert W., Frank I., Pomerantz R. J., HIV type 1 cervicovaginal reservoirs in the era of HAART AIDS Research and Human Retroviruses 2005 21 8 714 718 (Pubitemid 41254237)
101. Siliciano J. D., Kajdas J., Finzi D., Quinn T. C., Chadwick K., Margolick J. B., Kovacs C., Gange S. J., Siliciano R. F., Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4 + T cells Nature Medicine 2003 9 6 727 728 (Pubitemid 36749221)
102. Koelsch K. K., Liu L., Haubrich R., May S., Havlir D., Gnthard H. F., Ignacio C. C., Campos-Soto P., Little S. J., Shafer R., Robbins G. K., D'Aquila R. T., Kawano Y., Young K., Dao P., Spina C. A., Richman D. D., Wong J. K., Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro Journal of Infectious Diseases 2008 197 3 411 419 (Pubitemid 351263423)
103. Pasternak A. O., Jurriaans S., Bakker M., Prins J. M., Berkhout B., Lukashov V. V., Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome PLoS One 2009 4 12
104. d'Ettorre G., Paiardini M., Zaffiri L., Andreotti M., Ceccarelli G., Rizza C., Indinnimeo M., Vella S., Mastroianni C. M., Silvestri G., Vullo V., HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS Current HIV Research 2011 9 3 148 153
105. Neuhaus J., Jacobs D. R., Baker J. V., Calmy A., Duprez D., Rosa A. L., Kuller L. H., Pett S. L., Ristola M., Ross M. J., Shlipak M. G., Tracy R., Neaton J. D., Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection Journal of Infectious Diseases 2010 201 12 1788 1795
106. Kuller L. H., Tracy R., Belloso W., De Wit S., Drummond F., Lane H. C., Ledergerber B., Lundgren J., Neuhaus J., Nixon D., Paton N. I., Neaton J. D., Inflammatory and coagulation biomarkers and mortality in patients with HIV infection PLoS Medicine 2008 5 10, article e203
107. Eastburn A., Scherzer R., Zolopa A. R., Benson C., Tracy R., Do T., Bacchetti P., Shlipak M., Grunfeld C., Tien P. C., Association of low level viremia with inflammation and mortality in HIV-infected adults PLoS One 2011 6 11
108. Mugavero M. J., Napravnik S., Cole S. R., Eron J. J., Lau B., Crane H. M., Kitahata M. M., Willig J. H., Moore R. D., Deeks S. G., Saag M. S., Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy Clinical Infectious Diseases 2011 53 9 927 935
109. Cole S. R., Napravnik S., Mugavero M. J., Lau B., Eron J., Saag M. S., Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden American Journal of Epidemiology 2010 171 2 198 205
110. Argyropoulos C., Mouzaki A., Immunosuppressive drugs in HIV disease Current Topics in Medicinal Chemistry 2006 6 16 1769 1789 (Pubitemid 44323062)
111. Wilkin T., Lalama C., Tenorio A. R., Maraviroc intensification for suboptimal CD4 + cell response despite sustained virologic suppression: ATCG 5256 Proceedings of the 17th Conference on Retroviruses and Opportunistic Infections February 2010 San Francisco, Calif, USA. Abstract 285
112. Gutierrez C., Diaz L., Hernandez-Novoa B., Effect of the intensification with a CCR5 antagonist on the decay of the HIV-1 latent reservoir and residual viremia Proceedings of the 17th Conference on Retroviruses and Opportunistic Infections February 2010 San Francisco, Calif, USA. Abstract 284
113. Sierra-Madero J., Di Perri G., Wood R., Saag M., Frank I., Craig C., Burnside R., McCracken J., Pontani D., Goodrich J., Heera J., Mayer H., Efficacy and safety of maraviroc versus efavirenz, both with zidovudine/lamivudine: 96-week results from the MERIT study HIV Clinical Trials 2010 11 3 125 132
114. De Wit S., Delforge M., Necsoi C. V., Clumeck N., Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load AIDS 2011 25 10 1332 1333
115. Czeslick E., Struppert A., Simm A., Sablotzki A., E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes Inflammation Research 2006 55 11 511 515 (Pubitemid 44826742)
116. Connolly N. C., Riddler S. A., Rinaldo C. R., Proinflammatory cytokines in HIV diseasea review and rationale for new therapeutic approaches AIDS Reviews 2005 7 3 168 180 (Pubitemid 41671917)
117. Piconi S., Parisotto S., Rizzardini G., Passerini S., Terzi R., Argenteri B., Meraviglia P., Capetti A., Biasin M., Trabattoni D., Clerici M., Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders Blood 2011 118 12 3263 3272
118. Davey R. T., Murphy R. L., Graziano F. M., Boswell S. L., Pavia A. T., Cancio M., Nadler J. P., Chaitt D. G., Dewar R. L., Sahner D. K., Duliege A. M., Capra W. B., Leong W. P., Giedlin M. A., Lane H. C., Kahn J. O., Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: a randomized controlled trial JAMA 2000 284 2 183 189 (Pubitemid 30460861)
119. Katlama C., Carcelain G., Duvivier C., Chouquet C., Tubiana R., De Sa M., Zagury L., Calvez V., Autran B., Costagliola D., Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM studyANRS 082 AIDS 2002 16 15 2027 2034 (Pubitemid 35205266)
120. Levy Y., Durier C., Krzysiek R., Rabian C., Capitant C., Lascaux A. S., Michon C., Oksenhendler E., Weiss L., Gastaut J. A., Goujard C., Rouzioux C., Maral J., Delfraissy J. F., Emilie D., Aboulker J. P., Gougeon M. L., Metro A., Viard J. P., Bouchenafa K., Jung C., Mortier E., Bloch M., Chandemerle C., Gérard L., Martinie M., Kazatchkine M., Laureillard D., Dinh T. T., Dalmas A. M., Peretti D., Rannou M. T., Bazin C., Verdon R., Six M., Goubin P., Vittecoq D., Escaut L., Malet M., Maignan A., Bouvet E., Prevot M. H., Fournier I., Gaudebout C., Yéni P., Belarbi L., Mandet C., Zucman D., Majerholc C., Boue F., Estocq G. A., Delavalle A. M., Pasquali J. L., Lalanne H., Bouchet-Delbos L., Chambenoit C., Carmagnat M. V., Grangeot-Keros L., Ameisen J. C., Estaquier J., Monnier D., Ferchal F., Girard P. M., Laplanche A., Bazin B., Foubert V., Izard S., Martins J., Netzer E., Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial AIDS 2003 17 3 343 351 (Pubitemid 36223259)
121. Paredes R., Lpez Bernaldo De Quirs J. C., Fernndez-Cruz E., Clotet B., Lane H. C., The potential role of interleukin-2 in patients with HIV infection AIDS Reviews 2002 4 1 36 40 (Pubitemid 34464233)
122. Caggiari L., Zanussi S., Bortolin M. T., D'Andrea M., Nasti G., Simonelli C., Tirelli U., De Paoli P., Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4 + and CD8 + lymphocyte apoptosis in HIV+ patients Clinical and Experimental Immunology 2000 120 1 101 106 (Pubitemid 30176906)
123. Zou W., Fousst A., Capitant C., Durand-Gasselin I., Bouchet L., Galanaud P., Levy Y., Emilie D., Acute activation of CD8 + T lymphocytes in interleukin-2treated HIV- infected patients Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1999 22 1 31 38 (Pubitemid 29486907)
124. Kutza J., Hayes M. P., Clouse K. A., Interleukin-2 inhibits HIV-1 replication in human macrophages by modulating expression of CD4 and CC-chemokine receptor-5 AIDS 1998 12 8 F59 F64
125. Abrams D., Lévy Y., Losso M. H., Babiker A., Collins G., Cooper D. A., Darbyshire J., Emery S., Fox L., Gordin F., Lane H. C., Lundgren J. D., Mitsuyasu R., Neaton J. D., Phillips A., Routy J. P., Tambussi G., Wentworth D., Interleukin-2 therapy in patients with HIV infection The New England Journal of Medicine 2009 361 16 1548 1559
126. Emery S., Abrams D. I., Cooper D. A., Darbyshire J. H., Lane H. C., Lundgren J. D., Neaton J. D., The Evaluation of Subcutaneous Proleukin (interleukin-2) in a Randomized International Trial: rationale, design, and methods of ESPRIT Controlled Clinical Trials 2002 23 2 198 220 (Pubitemid 34273853)
127. Levy Y., Lacabaratz C., Weiss L., Viard J. P., Goujard C., Lelivre J. D., Boué F., Molina J. M., Rouzioux C., Avettand-Fénol V., Croughs T., Beq S., Thiébaut R., Chne G., Morre M., Delfraissy J. F., Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment The Journal of Clinical Investigation 2009 119 4 997 1007
128. Mackall C. L., Fry T. J., Bare C., Morgan P., Galbraith A., Gress R. E., IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation Blood 2001 97 5 1491 1497 (Pubitemid 32183777)
129. Oliva A., Kinter A. L., Vaccarezza M., Rubbert A., Catanzaro A., Moir S., Monaco J., Ehler L., Mizell S., Jackson R., Li Y., Romano J. W., Fauci A. S., Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro The Journal of Clinical Investigation 1998 102 1 223 231 (Pubitemid 28323849)
130. Prlic M., Blazar B. R., Farrar M. A., Jameson S. C., In vivo survival and homeostatic proliferation of natural killer cells Journal of Experimental Medicine 2003 197 8 967 976 (Pubitemid 36523194)
131. D'Ettorre G., Andreotti M., Ceccarelli G., Galluzzo C. M., Mallano A., Massetti A. P., Tierno F., Stella S., Amici R., Vella S., Mastroianni C. M., Vullo V., The role of IL-15 in challenging Acquired Immunodeficiency Syndrome Cytokine 2012 57 1 54 60
132. D'Ettorre G., Andreotti M., Carnevalini M., Andreoni C., Zaffiri L., Vullo V., Vella S., Mastroianni C. M., Interleukin-15 enhances the secretion of IFN- and CC chemokines by natural killer cells from HIV viremic and aviremic patients Immunology Letters 2006 103 2 192 195 (Pubitemid 43162935)
133. Tarkowski M., Ferraris L., Martone S., Expression of interleukin-15 and interleukin-15R in monocytes of HIV type 1-infected patients with different courses of disease progression. AIDS Research and Human Retroviruses. In press
134. Sereti I., Dunham R. M., Spritzler J., Aga E., Proschan M. A., Medvik K., Battaglia C. A., Landay A. L., Pahwa S., Fischl M. A., Asmuth D. M., Tenorio A. R., Altman J. D., Fox L., Moir S., Malaspina A., Morre M., Buffet R., Silvestri G., Lederman M. M., IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection Blood 2009 113 25 6304 6314
135. Wang F. X., Xu Y., Sullivan J., Souder E., Argyris E. G., Acheampong E. A., Fisher J., Sierra M., Thomson M. M., Najera R., Frank I., Kulkosky J., Pomerantz R. J., Nunnari G., IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART The Journal of Clinical Investigation 2005 115 1 128 137 (Pubitemid 40385513)
136. Vandergeeten C., DaFonseca S., Fromentin R., Differential impact of IL-7 and IL-15 on HIV reservoir persistence Proceedings of the 5th International Workshop on HIV Persistence during Therapy December 2011 St Maarten, West Indies. Abstract 29
137. Archin N. M., Keedy K. S., Espeseth A., Dang H., Hazuda D. J., Margolis D. M., Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors AIDS 2009 23 14 1799 1806
138. Ylisastigui L., Archin N. M., Lehrman G., Bosch R. J., Margolis D. M., Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression AIDS 2004 18 8 1101 1108 (Pubitemid 38738509)
139. Archin N. M., Eron J. J., Palmer S., Hartmann-Duff A., Martinson J. A., Wiegand A., Bandarenko N., Schmitz J. L., Bosch R. J., Landay A. L., Coffin J. M., Margolis D. M., Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4 + T cells AIDS 2008 22 10 1131 1135
140. Sagot-Lerolle N., Lamine A., Chaix M. L., Boufassa F., Aboulker J. P., Costagliola D., Goujard C., Paller C., Delfraissy J. F., Lambotte O., Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir AIDS 2008 22 10 1125 1129
141. Siliciano J. D., Lai J., Callender M., Pitt E., Zhang H., Margolick J. B., Gallant J. E., Cofrancesco J., Moore R. D., Gange S. J., Siliciano R. F., Stability of the latent reservoir for HIV-1 in patients receiving valproic acid Journal of Infectious Diseases 2007 195 6 833 836 (Pubitemid 46363928)
142. Kulkosky J., Culnan D. M., Roman J., Dornadula G., Schnell M., Boyd M. R., Pomerantz R. J., Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART Blood 2001 98 10 3006 3015
143. Reuse S., Calao M., Kabeya K., Guiguen A., Gatot J. S., Quivy V., Vanhulle C., Lamine A., Vaira D., Demonte D., Martinelli V., Veithen E., Cherrier T., Avettand V., Poutrel S., Piette J., de Launoit Y., Moutschen M., Burny A., Rouzioux C., De Wit S., Herbein G., Rohr O., Collette Y., Lambotte O., Clumeck N., Van Lint C., Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection PLoS One 2009 4 6
144. Mehla R., Bivalkar-Mehla S., Zhang R., Handy I., Albrecht H., Giri S., Nagarkatti P., Nagarkatti M., Chauhan A., Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner PLoS One 2010 5 6
145. Blazkova J., Trejbalova K., Gondois-Rey F., Halfon P., Philibert P., Guiguen A., Verdin E., Olive D., Van Lint C., Hejnar J., Hirsch I., CpG methylation controls reactivation of HIV from latency PLoS Pathogens 2009 5 8
146. Kauder S. E., Bosque A., Lindqvist A., Planelles V., Verdin E., Epigenetic regulation of HIV-1 latency by cytosine methylation PLoS Pathogens 2009 5 6
147. Lewis M. G., Dafonseca S., Chomont N., Palamara A. T., Tardugno M., Mai A., Collins M., Wagner W. L., Yalley-Ogunro J., Greenhouse J., Chirullo B., Norelli S., Garaci E., Savarino A., Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension AIDS 2011 25 11 1347 1356
148. Ensoli B., Bellino S., Tripiciano A., Longo O., Francavilla V., Marcotullio S., Cafaro A., Picconi O., Paniccia G., Scoglio A., Arancio A., Ariola C., Ruiz Alvarez M. J., Campagna M., Scaramuzzi D., Iori C., Esposito R., Mussini C., Ghinelli F., Sighinolfi L., Palamara G., Latini A., Angarano G., Ladisa N., Soscia F., Mercurio V. S., Lazzarin A., Tambussi G., Visintini R., Mazzotta F., Di Pietro M., Galli M., Rusconi S., Carosi G., Torti C., Di Perri G., Bonora S., Ensoli F., Garaci E., Therapeutic immunization with hiv-1 tat reduces immune activation and loss of regulatory t-cells and improves immune function in subjects on HAART PLoS One 2010 5 11
149. Autran B., Murphy R. L., Costagliola D., Tubiana R., Clotet B., Gatell J., Staszewski S., Wincker N., Assoumou L., El-Habib R., Calvez V., Walker B., Katlama C., Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452) AIDS 2008 22 11 1313 1322